Clinical trial NCT07022561: Social Prescribing for Advancing Resilience in Kids: A Pilot Study of Social Prescribing
Official title: Social Prescribing for Advancing Resilience in Kids (SPARK): A Pilot Study of Social Prescribing for Children and Youth Mental Health in Canada
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Youth Mental Health and Wellbeing
Feasibility and Acceptability of the Social Prescribing Program
Keywords: social prescribing
children and youth mental health
intervention
wellbeing
Lead sponsor: University of Ottawa
Sponsor class: OTHER
Collaborators: name: Children's Hospital of Eastern Ontario Research Institute
First posted: 2025-06-15
Enrollment: 170
Sex: ALL
Minimum age (years): 11
Maximum age (years): 17
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The goal of this clinical trial is to learn if the Social Prescription (SP) intervention helps improve mental health and wellbeing in youth. It will also assess the feasibility and acceptability of implementing SP in a community setting. The main questions it aims to answer are:

* Is the SP intervention feasible and acceptable for youth, caregivers, and staff?
* Does the SP intervention improve mental health outcomes, reduce stress, and increase wellbeing and social connectedness in youth?

Researchers will compare the Social Prescription (SP) intervention to an education control group to evaluate its effectiveness in improving youth mental health and wellbeing.

Participants will:

* Be randomized to receive either the SP intervention or be placed in an education control group
* Complete wellbeing and mental health questionnaires at the beginning of the study and again after 12 weeks
* Participate in qualitative interviews to share their experiences after participating in SP


Eligibility criteria: Inclusion Criteria:

* between 11-17 years of age
* on the waitlist for mental health services
* are not an immediate safety threat to themselves or others as assessed by the HEADS ED questionnaire

Exclusion Criteria:

* Children \< 11 years old
* Adolescents \> 17 years old

Primary outcomes:
measure: Revised Children's Anxiety and Depression Scale
timeFrame: From enrollment to end of treatment or control period at 12 weeks.
measure: Perceived Stress Scale
timeFrame: From enrollment to end of treatment or control period at 12 weeks.
measure: Warwick-Edinburgh Mental Wellbeing Scale
timeFrame: From enrollment to end of treatment or control period at 12 weeks
measure: Social Connectedness Scale
timeFrame: From enrollment to end of treatment or control period at 12 weeks
measure: Student Resilience Survey
timeFrame: From enrollment to end of treatment or control period at 12 weeks
Secondary outcomes:
measure: Acceptability of Intervention Measure
timeFrame: From enrollment to end of treatment or control period at 12 weeks
measure: Intervention Appropriateness Measure
timeFrame: From enrollment to end of treatment or control period at 12 weeks
measure: Feasibility of Intervention Measure
timeFrame: From enrollment to end of treatment or control period at 12 weeks
Other outcomes:
Locations:
city: Ottawa
country: Canada
facility: University of Ottawa
state: Ontario
Study officials:
affiliation: University of Ottawa
name: Nicole Racine, PhD
role: PRINCIPAL_INVESTIGATOR
References: